These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 3917428)
1. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Chan RC; Reid G; Irvin RT; Bruce AW; Costerton JW Infect Immun; 1985 Jan; 47(1):84-9. PubMed ID: 3917428 [TBL] [Abstract][Full Text] [Related]
2. Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion. Chan RC; Bruce AW; Reid G J Urol; 1984 Mar; 131(3):596-601. PubMed ID: 6422061 [TBL] [Abstract][Full Text] [Related]
3. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Reid G; Chan RC; Bruce AW; Costerton JW Infect Immun; 1985 Aug; 49(2):320-4. PubMed ID: 3926645 [TBL] [Abstract][Full Text] [Related]
4. Adherence of gram-negative uropathogens to human uroepithelial cells. Bruce AW; Chan RC; Pinkerton D; Morales A; Chadwick P J Urol; 1983 Aug; 130(2):293-8. PubMed ID: 6135810 [TBL] [Abstract][Full Text] [Related]
5. Adherence of gram-negative uropathogens to human uroepithelial cells. Polito M; Minardi D; Montanari MP; Varaldo PE Eur Urol; 1987; 13(1-2):74-8. PubMed ID: 3107998 [TBL] [Abstract][Full Text] [Related]
6. Mediation of Staphylococcus saprophyticus adherence to uroepithelial cells by lipoteichoic acid. Teti G; Chiofalo MS; Tomasello F; Fava C; Mastroeni P Infect Immun; 1987 Mar; 55(3):839-42. PubMed ID: 3818102 [TBL] [Abstract][Full Text] [Related]
7. The influence of growth media on the morphology and in vitro adherence characteristics of gram-negative urinary pathogens. Chan RC; Bruce AW J Urol; 1983 Feb; 129(2):411-7. PubMed ID: 6403715 [TBL] [Abstract][Full Text] [Related]
8. Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. Reid G; Cook RL; Bruce AW J Urol; 1987 Aug; 138(2):330-5. PubMed ID: 3599250 [TBL] [Abstract][Full Text] [Related]
10. Adherence of Escherichia coli to epithelial cells in the pathogenesis of urinary tract infection. Kozody NL; Harding GK; Nicolle LE; Kelly K; Ronald AR Clin Invest Med; 1985; 8(2):121-5. PubMed ID: 3914382 [TBL] [Abstract][Full Text] [Related]
13. Effect of antibiotic treatment on receptivity of uroepithelial cells to uropathogens. Reid G; Bruce AW; Beheshti M Can J Microbiol; 1988 Mar; 34(3):327-31. PubMed ID: 3262006 [TBL] [Abstract][Full Text] [Related]
14. Bacterial adherence to bladder uroepithelial cells in catheter-associated urinary tract infection. Daifuku R; Stamm WE N Engl J Med; 1986 May; 314(19):1208-13. PubMed ID: 3702917 [TBL] [Abstract][Full Text] [Related]
15. The urethra and its relationship to urinary tract infection. II. The urethral flora of the female with recurrent urinary infection. Cox CE; Lacy SS; Hinman F J Urol; 1968 May; 99(5):632-8. PubMed ID: 4869868 [No Abstract] [Full Text] [Related]
16. Lipoteichoic acids in Lactobacillus strains that colonize the mouse gastric epithelium. Sherman LA; Savage DC Appl Environ Microbiol; 1986 Aug; 52(2):302-4. PubMed ID: 3752995 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. Osset J; Bartolomé RM; García E; Andreu A J Infect Dis; 2001 Feb; 183(3):485-91. PubMed ID: 11133381 [TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of a uroepithelial cell adhesin from a uropathogenic isolate of Proteus mirabilis. Wray SK; Hull SI; Cook RG; Barrish J; Hull RA Infect Immun; 1986 Oct; 54(1):43-9. PubMed ID: 2875952 [TBL] [Abstract][Full Text] [Related]
19. [Studies on the virulent factor of Escherichia coli isolated from urogenital infection--pilus type and adherence to human exfoliated uroepithelial cells etc]. Hibi H; Ishikawa K; Izumitani M; Tanaka T; Naide Y Hinyokika Kiyo; 1991 Nov; 37(11):1525-9. PubMed ID: 1685066 [TBL] [Abstract][Full Text] [Related]
20. Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets. Mendes RE; Castanheira M; Woosley LN; Stone GG; Bradford PA; Flamm RK Int J Antimicrob Agents; 2018 Aug; 52(2):287-292. PubMed ID: 29654893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]